Gynecologic Procedures Segment Is The Largest Segment Driving The Growth Of Laparoscopic Power Morcellators Market
The global Laparoscopic Power Morcellators Market is estimated to be valued at US$ 113.21 Mn or million in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Laparoscopic power morcellators are medical devices used for minimally invasive procedures for the removal of tissues such as uterus (hysterectomy) or fibroids. It divides tissues into smaller fragments so that they can be easily removed from the small incisions made in the body during laparoscopy.
Market key trends:
One of the key trend in the market is the increasing preference for minimally invasive surgeries. Laparoscopic power morcellators are increasingly being used for gynecologic procedures such as hysterectomy and myomectomy owing to benefits such as reduced postoperative pain, lesser morbidity and faster recovery time compared to open abdominal surgeries. Furthermore, technological advancements in morcellators such as bagless morcellation and improved blade design are also fueling the growth of laparoscopic power morcellators market.
SWOT Analysis
Strength: Laparoscopic procedures using power morcellators enable reduced trauma, blood loss, recovery time and scarring compared to open surgeries. They offer improved visualization of internal organs and high accuracy.
Weakness: Safety concerns over risk of spreading cancerous cells in case of undetected sarcoma. Strict regulatory guidelines and restrictions on power morcellators in certain countries.
Opportunity: Growing prevalence of uterine fibroids and hysterectomies drives demand. Developing healthcare infrastructure and rising medical tourism in emerging nations.
Threats: Alternative morcellation techniques gaining popularity. Litigations over safety issues raise concerns. Intense competition.
Key Takeaways
Global Laparoscopic Power Morcellators Market Size was valued at US$ 113.21 Mn in 2023 and is expected to reach US$ 210.45 Mn by 2030, expanding at a CAGR of 5.3% during the forecast period.
Growing preference for minimally invasive procedures over conventional open surgeries and rising prevalence of hysterectomies and myomectomies for uterine conditions like fibroids are expected to propel market growth.
Regionally, North America dominated the market in 2023 and is likely to maintain its lead, followed by Europe. Some key players in the laparoscopic power morcellators market are LiNA medical, Blue endo, Johnson and Johnson, Hangzhou kangji medical instruments, WISAP medical technology, Zhejiang geyi medical instrument, Karl storz GmbH, Medtronic, Richard wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation.
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian